Using a murine model of a Dkk-1 expressing OS, we demonstrated that DkkMo reduces tumour progression through reduction of cell proliferation, perturbation of survival mechanisms, inhibition of bone destruction, and through depletion of the tumour stroma. Here, DKK1 is linked to neoplasm.